Cargando…
Can Pure Predictions of Activity Coefficients from PC-SAFT Assist Drug–Polymer Compatibility Screening?
[Image: see text] The bioavailability of poorly water-soluble active pharmaceutical ingredients (APIs) can be improved via the formulation of an amorphous solid dispersion (ASD), where the API is incorporated into a suitable polymeric carrier. Optimal carriers that exhibit good compatibility (i.e.,...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410664/ https://www.ncbi.nlm.nih.gov/pubmed/37386723 http://dx.doi.org/10.1021/acs.molpharmaceut.3c00124 |
_version_ | 1785086508419514368 |
---|---|
author | Pavliš, Jáchym Mathers, Alex Fulem, Michal Klajmon, Martin |
author_facet | Pavliš, Jáchym Mathers, Alex Fulem, Michal Klajmon, Martin |
author_sort | Pavliš, Jáchym |
collection | PubMed |
description | [Image: see text] The bioavailability of poorly water-soluble active pharmaceutical ingredients (APIs) can be improved via the formulation of an amorphous solid dispersion (ASD), where the API is incorporated into a suitable polymeric carrier. Optimal carriers that exhibit good compatibility (i.e., solubility and miscibility) with given APIs are typically identified through experimental means, which are routinely labor- and cost-inefficient. Therefore, the perturbed-chain statistical associating fluid theory (PC-SAFT) equation of state, a popular thermodynamic model in pharmaceutical applications, is examined in terms of its performance regarding the computational pure prediction of API–polymer compatibility based on activity coefficients (API fusion properties were taken from experiments) without any binary interaction parameters fitted to API–polymer experimental data (that is, k(ij) = 0 in all cases). This kind of prediction does not need any experimental binary information and has been underreported in the literature so far, as the routine modeling strategy used in the majority of the existing PC-SAFT applications to ASDs comprised the use of nonzero k(ij) values. The predictive performance of PC-SAFT was systematically and thoroughly evaluated against reliable experimental data for almost 40 API–polymer combinations. We also examined the effect of different sets of PC-SAFT parameters for APIs on compatibility predictions. Quantitatively, the total average error calculated over all systems was approximately 50% in the weight fraction solubility of APIs in polymers, regardless of the specific API parametrization. The magnitude of the error for individual systems was found to vary significantly from one system to another. Interestingly, the poorest results were obtained for systems with self-associating polymers such as poly(vinyl alcohol). Such polymers can form intramolecular hydrogen bonds, which are not accounted for in the PC-SAFT variant routinely applied to ASDs (i.e., that used in this work). However, the qualitative ranking of polymers with respect to their compatibility with a given API was reasonably predicted in many cases. It was also predicted correctly that some polymers always have better compatibility with the APIs than others. Finally, possible future routes to improve the cost–performance ratio of PC-SAFT in terms of parametrization are discussed. |
format | Online Article Text |
id | pubmed-10410664 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-104106642023-08-10 Can Pure Predictions of Activity Coefficients from PC-SAFT Assist Drug–Polymer Compatibility Screening? Pavliš, Jáchym Mathers, Alex Fulem, Michal Klajmon, Martin Mol Pharm [Image: see text] The bioavailability of poorly water-soluble active pharmaceutical ingredients (APIs) can be improved via the formulation of an amorphous solid dispersion (ASD), where the API is incorporated into a suitable polymeric carrier. Optimal carriers that exhibit good compatibility (i.e., solubility and miscibility) with given APIs are typically identified through experimental means, which are routinely labor- and cost-inefficient. Therefore, the perturbed-chain statistical associating fluid theory (PC-SAFT) equation of state, a popular thermodynamic model in pharmaceutical applications, is examined in terms of its performance regarding the computational pure prediction of API–polymer compatibility based on activity coefficients (API fusion properties were taken from experiments) without any binary interaction parameters fitted to API–polymer experimental data (that is, k(ij) = 0 in all cases). This kind of prediction does not need any experimental binary information and has been underreported in the literature so far, as the routine modeling strategy used in the majority of the existing PC-SAFT applications to ASDs comprised the use of nonzero k(ij) values. The predictive performance of PC-SAFT was systematically and thoroughly evaluated against reliable experimental data for almost 40 API–polymer combinations. We also examined the effect of different sets of PC-SAFT parameters for APIs on compatibility predictions. Quantitatively, the total average error calculated over all systems was approximately 50% in the weight fraction solubility of APIs in polymers, regardless of the specific API parametrization. The magnitude of the error for individual systems was found to vary significantly from one system to another. Interestingly, the poorest results were obtained for systems with self-associating polymers such as poly(vinyl alcohol). Such polymers can form intramolecular hydrogen bonds, which are not accounted for in the PC-SAFT variant routinely applied to ASDs (i.e., that used in this work). However, the qualitative ranking of polymers with respect to their compatibility with a given API was reasonably predicted in many cases. It was also predicted correctly that some polymers always have better compatibility with the APIs than others. Finally, possible future routes to improve the cost–performance ratio of PC-SAFT in terms of parametrization are discussed. American Chemical Society 2023-06-30 /pmc/articles/PMC10410664/ /pubmed/37386723 http://dx.doi.org/10.1021/acs.molpharmaceut.3c00124 Text en © 2023 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Pavliš, Jáchym Mathers, Alex Fulem, Michal Klajmon, Martin Can Pure Predictions of Activity Coefficients from PC-SAFT Assist Drug–Polymer Compatibility Screening? |
title | Can Pure
Predictions of Activity Coefficients from
PC-SAFT Assist Drug–Polymer Compatibility Screening? |
title_full | Can Pure
Predictions of Activity Coefficients from
PC-SAFT Assist Drug–Polymer Compatibility Screening? |
title_fullStr | Can Pure
Predictions of Activity Coefficients from
PC-SAFT Assist Drug–Polymer Compatibility Screening? |
title_full_unstemmed | Can Pure
Predictions of Activity Coefficients from
PC-SAFT Assist Drug–Polymer Compatibility Screening? |
title_short | Can Pure
Predictions of Activity Coefficients from
PC-SAFT Assist Drug–Polymer Compatibility Screening? |
title_sort | can pure
predictions of activity coefficients from
pc-saft assist drug–polymer compatibility screening? |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410664/ https://www.ncbi.nlm.nih.gov/pubmed/37386723 http://dx.doi.org/10.1021/acs.molpharmaceut.3c00124 |
work_keys_str_mv | AT pavlisjachym canpurepredictionsofactivitycoefficientsfrompcsaftassistdrugpolymercompatibilityscreening AT mathersalex canpurepredictionsofactivitycoefficientsfrompcsaftassistdrugpolymercompatibilityscreening AT fulemmichal canpurepredictionsofactivitycoefficientsfrompcsaftassistdrugpolymercompatibilityscreening AT klajmonmartin canpurepredictionsofactivitycoefficientsfrompcsaftassistdrugpolymercompatibilityscreening |